Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Amortization of Deferred Charges (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Amortization of Deferred Charges readings, the most recent being $69000.0 for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges fell 8.0% to $69000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $292000.0, a 2.01% decrease, with the full-year FY2025 number at $292000.0, down 2.01% from a year prior.
  • Amortization of Deferred Charges hit $69000.0 in Q4 2025 for Treace Medical Concepts, down from $75000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $75000.0 in Q4 2022 to a low of $43000.0 in Q1 2021.
  • Median Amortization of Deferred Charges over the past 5 years was $74000.0 (2022), compared with a mean of $65350.0.
  • Biggest five-year swings in Amortization of Deferred Charges: tumbled 33.85% in 2021 and later surged 74.42% in 2022.
  • Treace Medical Concepts' Amortization of Deferred Charges stood at $43000.0 in 2021, then surged by 74.42% to $75000.0 in 2022, then fell by 1.33% to $74000.0 in 2023, then grew by 1.35% to $75000.0 in 2024, then decreased by 8.0% to $69000.0 in 2025.
  • The last three reported values for Amortization of Deferred Charges were $69000.0 (Q4 2025), $75000.0 (Q3 2025), and $74000.0 (Q2 2025) per Business Quant data.